TNF and neoplasm: Collectively, hPSC-derived CAR-neutrophils, particularly CD3ζ-bearing CAR-neutrophils, presented enhanced anti-tumor cytotoxicity and produced more ROS and TNF-α in vitro, highlighting their potential in targeted immunotherapy.